The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF -Mutated Melanoma Patients Treated With Targeted Therapy-What Can Be Learned From Progression?.

Subjects

Subjects :

All institutes and research themes of the Radboud University Medical Center.
Radboudumc 18: Healthcare improvement science Medical Oncology.

Details

Database :

OAIster

Notes :

Aalbersberg, E.A. author., Eertwegh, A.J.M. van den author., Wit-van der Veen, L.J. de author., Stokkel, M.P. author., Lopez-Yurda, M. author., Boellaard, R. author., Kapiteijn, E.W. author., Hospers, G.A.P. author., Aarts, M.J.B. author., Vos, F.Y.F.L. de author., Boers-Sonderen, M.J. author., Veldt, A.A. van der author., Groot, J.W.B. de author., Haanen, J.B.A.G. author.

Accession number :

edsoai.on1443199720